List view / Grid view

Dr Sam Rulli

 

article

Expert view: Overcoming NGS obstacles

Using next-generation sequencing techniques enables pharmaceutical companies to explore the…

12 September 2017 | By

Using next-generation sequencing techniques enables pharmaceutical companies to explore the molecular landscape of disease initiation and progression with unprecedented clarity. Dr Sam Rulli, Product Manager at QIAGEN, provides his insight into the major challenges researchers face...